25.69
price down icon0.83%   -0.216
after-market Dopo l'orario di chiusura: 25.60 -0.091 -0.35%
loading
Precedente Chiudi:
$25.91
Aprire:
$26.07
Volume 24 ore:
23,036
Relative Volume:
1.38
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.77%
1M Prestazione:
+5.69%
6M Prestazione:
-12.53%
1 anno Prestazione:
-1.76%
Intervallo 1D:
Value
$25.60
$26.11
Intervallo di 1 settimana:
Value
$25.37
$26.11
Portata 52W:
Value
$23.97
$30.11

Tema Oncology Etf Stock (CANC) Company Profile

Name
Nome
Tema Oncology Etf
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
CANC's Discussions on Twitter

Confronta CANC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Exchange Traded Fund icon
CANC
Tema Oncology Etf
25.69 0 0 0 0 0.00
Exchange Traded Fund icon
VTI
Vanguard Total Stock Market Etf
298.60 417.53B 0 0 0 0.00
Exchange Traded Fund icon
SPY
Spdr S P 500 Etf Trust
601.82 372.57B 0 0 0 0.00
Exchange Traded Fund icon
IVV
Ishares Core S P 500 Etf
604.66 253.41B 0 0 0 0.00
Exchange Traded Fund icon
VB
Vanguard Small Cap Etf
249.64 160.59B 0 0 0 0.00
Exchange Traded Fund icon
QQQ
Invesco Qqq Trust Series 1
522.29 124.43B 0 0 0 0.00

Tema Oncology Etf Borsa (CANC) Ultime notizie

pulisher
Jan 31, 2025

(CANC) Long Term Investment Analysis - Stock Traders Daily

Jan 31, 2025
pulisher
Jan 20, 2025

(CANC) Trading Report - Stock Traders Daily

Jan 20, 2025
pulisher
Jan 18, 2025

Tema Oncology ETF (NASDAQ:CANC) Short Interest Update - Defense World

Jan 18, 2025
pulisher
Jan 09, 2025

How To Trade (CANC) - Stock Traders Daily

Jan 09, 2025
pulisher
Dec 30, 2024

Trading (CANC) With Integrated Risk Controls - Stock Traders Daily

Dec 30, 2024
pulisher
Dec 29, 2024

Tema Oncology ETF (NASDAQ:CANC) Shares Sold by Jane Street Group LLC - Defense World

Dec 29, 2024
pulisher
Dec 11, 2024

Reshoring ETF Gets Boost From Trump Trade - etf.com

Dec 11, 2024
pulisher
Dec 09, 2024

Long Term Trading Analysis for (CANC) - Stock Traders Daily

Dec 09, 2024
pulisher
Dec 04, 2024

Tema's New VOLT ETF Sparked by AI Revolution - etf.com

Dec 04, 2024
pulisher
Nov 21, 2024

Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends

Nov 21, 2024
pulisher
Nov 17, 2024

(CANC) Investment Analysis - Stock Traders Daily

Nov 17, 2024
pulisher
Nov 15, 2024

Pacer Data and Digital Revolution ETF (TRFK) Institutional Ownership 2024 - MarketBeat

Nov 15, 2024
pulisher
Nov 07, 2024

(CANC) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 07, 2024
pulisher
Nov 03, 2024

7 Best-Performing Biotech ETFs for November 2024 - NerdWallet

Nov 03, 2024
pulisher
Oct 29, 2024

The 5 Best Biotech ETFs of 2024 - TradingView

Oct 29, 2024
pulisher
Oct 14, 2024

5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network

Oct 14, 2024
pulisher
Oct 06, 2024

(CANC) Trading Advice - Stock Traders Daily

Oct 06, 2024
pulisher
Sep 27, 2024

Thrivent Financial for Lutherans Invests $8.62 Million in Tema Oncology ETF (NASDAQ:CANC) - Defense World

Sep 27, 2024
pulisher
Sep 27, 2024

National Bankshares Cuts Lucero Energy (CVE:LOU) Price Target to C$0.75 - Defense World

Sep 27, 2024
pulisher
Sep 25, 2024

(CANC) Technical Data - Stock Traders Daily

Sep 25, 2024
pulisher
Aug 30, 2024

Where are the Opportunities in (CANC) - Stock Traders Daily

Aug 30, 2024
pulisher
Aug 13, 2024

Tema Oncology ETF (NASDAQ:CANC) Sees Large Decrease in Short Interest - Defense World

Aug 13, 2024
pulisher
Aug 07, 2024

When the Price of (CANC) Talks, People Listen - Stock Traders Daily

Aug 07, 2024
pulisher
Jul 25, 2024

Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha

Jul 25, 2024
pulisher
May 23, 2024

Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - Opto RoW

May 23, 2024
pulisher
May 17, 2024

9 Best Biotech ETFs for 2024 - MSN

May 17, 2024
pulisher
Apr 25, 2024

How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily

Apr 25, 2024
pulisher
Apr 22, 2024

10 Best Performing Biotech ETFs in 2024 - Yahoo Finance

Apr 22, 2024
pulisher
Apr 09, 2024

11 Best Biotech ETFs To Buy - Yahoo Finance

Apr 09, 2024
pulisher
Apr 08, 2024

Healthcare ETFs for the Weight-Loss Drug Boom & Beyond - Yahoo Finance

Apr 08, 2024
pulisher
Mar 27, 2024

Viking Therapeutics' weight-loss tablet shows promise in small study - ETHealthWorld

Mar 27, 2024
pulisher
Jan 22, 2024

Is Gilead's 10% Crash — Resulting In A Failed Breakout — An Overreaction? - Investor's Business Daily

Jan 22, 2024
pulisher
Dec 04, 2023

Sanofi CEO under pressure to woo investors after spending shock - Reuters.com

Dec 04, 2023
pulisher
Nov 22, 2023

Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters

Nov 22, 2023
pulisher
Sep 06, 2023

12 Best Healthcare ETFs To Buy - Yahoo Finance

Sep 06, 2023
pulisher
Sep 01, 2023

Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq

Sep 01, 2023
pulisher
Aug 21, 2023

Royalties and cancer treatments: Thematic ETFs take new directions - InvestmentNews

Aug 21, 2023
pulisher
Aug 19, 2023

How BlackRock’s Rick Rieder is steering his active fixed-income ETF as bond funds struggle - MarketWatch

Aug 19, 2023
pulisher
Aug 18, 2023

This Week in ETFs: 2 Funds Launch From Tema - ETFdb.com

Aug 18, 2023
pulisher
Aug 17, 2023

Tema Launches Two Innovative, Active ETF Thematic Strategies: Oncology & Global Royalties - Business Wire

Aug 17, 2023
pulisher
May 11, 2023

Tema launches three innovative, professionally managed thematic ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies - Business Wire

May 11, 2023
pulisher
Mar 02, 2022

Ukroboronprom to Repair Captured Russian Tanks for Use by Ukrainian Army - Defense World

Mar 02, 2022
pulisher
May 21, 2021

Getting in on global luxury - ETF Strategy

May 21, 2021
pulisher
Oct 25, 2018

Biotechnology ETF List - ETFdb.com

Oct 25, 2018

Tema Oncology Etf Azioni (CANC) Dati Finanziari

Non sono disponibili dati finanziari per Tema Oncology Etf (CANC). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
exchange_traded_fund VTV
$176.70
price down icon 0.60%
exchange_traded_fund VUG
$418.35
price down icon 0.38%
exchange_traded_fund IJH
$64.65
price down icon 0.92%
exchange_traded_fund EFA
$79.24
price down icon 0.94%
exchange_traded_fund IWF
$409.31
price down icon 0.35%
exchange_traded_fund QQQ
$522.29
price down icon 0.15%
Capitalizzazione:     |  Volume (24 ore):